Retno Arianingrum, Yogyakarta State University, Indonesia


Chalcone derivate compound [3-(4’-hydroxy-3’-methoxyphenyl) -1-phenyl-2- propene-1-on)] or para hydroxyl meta methoxy chalcone (pHmMC) has been observed. It showed that it is able to induce apoptosis (cell death) in MCF-7 breast cancer cell. This study was aimed at fi nding out the apoptosis mechanism pathway of pHmMC on MCF-7 cells by observing its effect on Bcl-2 and Bax proteins. The protein expression was observed by using immunocytochemistry (ICC) and analyzed using ImageJ software. The results showed that the pHmMC induce apoptosis through mechanism that decrease expression of Bcl-2 and increase expresion of Bax proteins.


[3- (4’-hydroxy-3’-methoxyphenyl) -1-phenyl-2-propene-1-on)] or para hydroxyl meta methoxy chalcone (pHmMC; Bcl-2 and Bax

Full Text:



Amundson, S. A., Myers, T. G., Scudiero, D., Kitada, S., Reed, J. C., & Fornace, A. J. (2000). An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res, 60, 6101-6110.

Arianingrum, R., Arty, I. S., & Atun, S. (2010). Uji sitotoksisitas senyawa mono para hidroksi kalkon terhadap cancer cell lines T47D. Saintek, 16(2), 121 -132.

Arianingrum, R., Sunarminingsih, R., Meiyanto, E., & Mubarika, S. (2012, June). Potential of a chalcone derivate compound as cancer chemoprevention in breast cancer. Dalam Proceedings of the 2012 3rd International Conferen-ce on Chemistry and Chemical Engineer- ing IPCBEE, Singapore (pp. 29-30).

Arianingrum, R., Sunarminingsih R., Meiyanto, E., & Mubarika, S. (2015, May). Cytotoxic effect of para hydroxy meta methoxy chalcone (pHmMC) on MCF-7 breast cancer cells by inducing cell arrest and apoptosis. Dalam Proceedings of International Conference on Research, Implementation and Education of Mathematics and Sciences 2015 (pp. C-89-C95). Yogyakarta State University.

Arty, I. S. (2010). Synthesize and citotoxicity test of several compounds of mono para-hidroxy chalcone. Indo. J. Chem. 10(1), 110-115.

Arty, I. S., Timmerman, H., Samhoedi, M., Sastrohamidjojo, Sugiyanto, & van der Goot, H. (2000). Synthesis of benzylideneacetophenones and their inhibition of lipid peroxidation. European Journal of Medicinal Chemistry, 35(4), 449-457.

Boumendjel, A., Ronot, X., & Boutonnat, J. (2009). Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs? Current drug targets, 10(4), 363-371.

Brown, M., & Attardi, L. D. (2005). The role of apoptosis in cancer development and treatmen response. Nature Rev. Cancer, 5, 231-236.

Butt, A. J., Firth, S. M., King, M. A., & Baxter, R. C. (2000). Insulin-like growth factor-binding protein-3 modulates expression of bax and bcl2 and potentiates P53-independent radiation-induced apoptosis in human breast cancer cells. J. Biol Chem, 275(50), 39174-39181. Pengaruh p-Hidroksi m-Metoksi Kalkon (Arianingrum, A., dkk.)

D’Archivio, M., Santangelo, C., Scazzochio, B., Vari, R., Filesi, C., Massela, R., & Giovannini, C. (2008). Modulatory effect of polyphenol on apoptosis induction relevance for cancer prevention. Int. J. Mol. Sci, 9, 213-228. Danial, N. N., & Korsmeyer, S.J. 2004. Cell Death: Critical Control points. Cell, 11 6 , 205-219.

Davis, J. M., Navolanic, P. M., WeinsteinOppenheimer, C. R., Steelman, L.S.,Wei, H., Konopleva, M., Blagosklonny, M. V., & McCubrey, J. A.(2003). Raf-1and Bcl-2 Induce distinc and common pathways that contribute tobreast cancer drug resistantce.Clin. Cancer Res., 9, 1161-1170.

Fan, T-J., Han, L-H, Cong, R-S., & Liang. J. (2005). Caspase family proteases and apoptosis. Acta Biochim. Biophys. Sin., 37(11), 719-727.

Ferreira, G. C., Epping, M., Kruyt, F. A. E., & Giaccone, G. (2002). Apoptosis: Target of cancer therapy. Clin. Cancer Research, 8, 2024-2034.

Hsu, Y. L., Kuo, P. L., Tzeng, W. W., & Lin, C. C. (2006). Chalcone Inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food Chem Toxicol, 44(5), 704-713.

Igney, F. H., & Krammer, P. H. (2002). Review: Death and anti-death: Tumor Resistance to Apoptosis. Nature Review: Cancer, 2, 277-286.

Khan, N., Afag, F., & Mukhtar, H. (2007). Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis, 88(2), 233-239.

King, R. J. B. (2000). Cancer biology (2 ed.). England: Pearson Education.

Kroemmer, G., & Martin, S. J. (2005). Caspase-independent cell death. Nature Med., 11(7), 725 730. Nd 19

Martin, K. R. (2006). Targeting apoptosis with dietary bioactive agents. Exp. Biol. Med., 231, 117-129.

Okada, H., & Mak, T. W. (2004). Pathway of Apoptotic and non-apoptotic death in tumour cells. Nature Rev. Cancer, 4, 592-603.

Pahl, H. L.. (1999). Activators and Target genes of rel/NF-κB transcriptionfactors. Oncogene, 18, 6853-6866.

Saraste, A., & Pulkki, K. (2000). Morphologic and biochemical hallmarks of apoptosis. Cardiovascular Research, 45, 528-537.

Sen, R., & Baltimore, D. (1986). Inducibility of kappa immunoglobulin enhancerbinding protein Nf-kappa B by a posttranslational mechanism. Cell, 47, 921-928.

Shah, A., Khan, A. M., Qureshi, R., Ansari, F. L., Nazar, M. F., & Shah, S. S. (2008). Redox behavior of anticancer chalcone on a glassy carbon electrode and evaluation of its interaction parameters with DNA. International journal of 20 molecular sciences, 9(8), 1424-1434.

Shen, K. H., Chang, J. K., Hsu, Y. L., & Kuo, P. L. (2007). Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclearfactor kappa B signalling in human bladder cancer cells. Basic & clinical pharmacology & toxicology, 101(4), 254-261.

Srinivasan B., Johnson T.E., Lad R., Xing C. (2009). Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'tetramethoxychalcone and its Analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. J Med Chem., 52, 72287235.

Tjindarbumi, D., & Mangunkusumo, R. (2002). Cancer in Indonesia, present and future. Jpn. J. Clin. Oncol., 32 (Supplement 1), S17-21. WHO. (2006). Cancer control, knowlendge into action. WHO Guide for EffectiveProgrames, diunduh dari http://www.

Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006). A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. The Journal of Pharmacology and Experimental Therapeutics, 317(3), 1372-1381.

Zimmerman, K. C., Bonzon, C., &Green, R.D. (2001). The machinery of programmed cell death. Pharmacology and Therapeutics, 92, 57-70.



  • There are currently no refbacks.

Copyright (c) 2017 Jurnal Penelitian Saintek

 p-ISSN: 1412-3991 || e-ISSN: 2528-7036

Indexed by:


View My Stats